SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001548123-12-000374
Filing Date
2012-11-14
Accepted
2012-11-14 15:40:07
Documents
10
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ON FORM 10Q FOR THE QUARTER ENDED SEPTEMBER 30, 2012 sanguineform10qsept12.htm 10-Q 275475
2 302 CERTIFICATION OF CEO ex311.htm EX-31 7312
3 302 CERTIFICATION OF CFO ex312.htm EX-31 7306
4 906 CERTIFICATION ex32.htm EX-32 4271
  Complete submission text file 0001548123-12-000374.txt   1818542

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT sgnc-20120930.xml EX-101.INS 147309
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgnc-20120930_pre.xml EX-101.PRE 108641
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sgnc-20120930_lab.xml EX-101.LAB 137792
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgnc-20120930_def.xml EX-101.DEF 89746
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgnc-20120930_cal.xml EX-101.CAL 32917
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgnc-20120930.xsd EX-101.SCH 26035
Mailing Address 110 FOUNDERS MILL COURT ROSWELL GA 30075
Business Address 110 FOUNDERS MILL COURT ROSWELL GA 30075 678-352-9060
SANGUINE CORP (Filer) CIK: 0000926287 (see all company filings)

IRS No.: 954347608 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24480 | Film No.: 121204092
SIC: 2835 In Vitro & In Vivo Diagnostic Substances